Sampling from four geographically divergent young female populations demonstrates forensic geolocation potential in microbiomes
-
Quality control
- Retracted paper
- Contamination issues suspected
- Batch effect issues suspected
- Uncontrolled confounding suspected
- Results are suspect (various reasons)
- Tags applied
Experiment 3
Subjects
- Location of subjects
- Barbados
- Chile
- South Africa
- Thailand
- Host species Species from which microbiome was sampled. Contact us to have more species added.
- Homo sapiens
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
- Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
- Lifestyle measurement Lifestyle measurement,lifestyle measurement
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Barbados, Chile, South Africa
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Thailand
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Thailand refers to the samples from healthy females aged between 18 and 26 years, based in Thailand.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 138
- Group 1 sample size Number of subjects in the case (exposed) group
- 68
- Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
- Participants currently taking antibiotics were excluded from the study.
Lab analysis
- Sequencing type
- 16S
- 16S variable region One or more hypervariable region(s) of the bacterial 16S gene
- V4
- Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
- Illumina
Statistical Analysis
- Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
- raw counts
- Statistical test
- DESeq2
- Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
- 0.05
- MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
- Yes
Signature 1
Source: Table S8
Description: Differentially abundant taxa in stool samples for Thailand location.
Abundance in Group 1: increased abundance in Thailand
Revision editor(s): KateRasheed
Signature 2
Source: Table S8
Description: Differentially abundant taxa in stool samples for Thailand location.
Abundance in Group 1: decreased abundance in Thailand
Revision editor(s): KateRasheed
Experiment 4
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Chile, South Africa, Thailand
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Barbados
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Barbados refers to the samples from healthy females aged between 18 and 26 years, based in Barbados.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 174
- Group 1 sample size Number of subjects in the case (exposed) group
- 32
Lab analysis
Statistical Analysis
Signature 1
Source: Table S9
Description: Differentially abundant taxa in stool samples for Barbados location.
Abundance in Group 1: increased abundance in Barbados
NCBI | Quality Control | Links |
---|---|---|
uncultured Pseudobutyrivibrio sp. | ||
Bacteroides ovatus | ||
Lachnospiraceae_UCG-004Lachnospiraceae_UCG-004 | ||
Lachnospiraceae_UCG-005Lachnospiraceae_UCG-005 | ||
uncultured Bacteroides sp. |
Revision editor(s): KateRasheed
Signature 2
Source: Table S9
Description: Differentially abundant taxa in stool samples for Barbados location.
Abundance in Group 1: decreased abundance in Barbados
Revision editor(s): KateRasheed
Experiment 5
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Barbados, South Africa, and Thailand
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Chile
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Chile refers to the samples from healthy females aged between 18 and 26 years, based in Chile.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 137
- Group 1 sample size Number of subjects in the case (exposed) group
- 69
Lab analysis
Statistical Analysis
Signature 1
Source: Table S10
Description: Differentially abundant taxa in stool samples for Chile location.
Abundance in Group 1: increased abundance in Chile
NCBI | Quality Control | Links |
---|---|---|
Ruminococcaceae_UCG-005Ruminococcaceae_UCG-005 |
Revision editor(s): KateRasheed
Signature 2
Source: Table S10
Description: Differentially abundant taxa in stool samples for Chile location.
Abundance in Group 1: decreased abundance in Chile
Revision editor(s): KateRasheed
Experiment 6
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Barbados, Chile, and Thailand
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- South Africa
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- South Africa refers to the samples from healthy females aged between 18 and 26 years, based in South Africa.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 169
- Group 1 sample size Number of subjects in the case (exposed) group
- 37
Lab analysis
Statistical Analysis
Signature 1
Source: Table S11
Description: Differentially abundant taxa in stool samples between South Africa and other location.
Abundance in Group 1: increased abundance in South Africa
NCBI | Quality Control | Links |
---|---|---|
uncultured Faecalibacterium sp. | ||
unclassified Bifidobacterium | ||
Ruminococcaceae_UCG-002Ruminococcaceae_UCG-002 | ||
unclassified Faecalibacterium |
Revision editor(s): KateRasheed
Signature 2
Source: Table S11
Description: Differentially abundant taxa in stool samples between South Africa and other location.
Abundance in Group 1: decreased abundance in South Africa
Revision editor(s): KateRasheed
Experiment 7
Subjects
- Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
- Cheek Buccae,Jowl,Cheek,cheek
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Barbados, Chile, and South Africa
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Thailand
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Thailand refers to the oral samples from healthy females aged between 18 and 26 years, based in Thailand.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 138
- Group 1 sample size Number of subjects in the case (exposed) group
- 68
Lab analysis
Statistical Analysis
Signature 1
Source: Table S12
Description: Differentially abundant taxa in oral samples between Thailand and other location.
Abundance in Group 1: increased abundance in Thailand
NCBI | Quality Control | Links |
---|---|---|
Streptococcus sanguinis | ||
unclassified Haemophilus | ||
uncultured Aggregatibacter sp. | ||
uncultured Bergeyella sp. | ||
uncultured gemellauncultured gemella | ||
uncultured Neisseria sp. |
Revision editor(s): KateRasheed
Signature 2
Source: Table S12
Description: Differentially abundant taxa in oral samples between Thailand and other location.
Abundance in Group 1: decreased abundance in Thailand
Revision editor(s): KateRasheed
Experiment 8
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Chile, South Africa, Thailand
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Barbados
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Barbados refers to the samples from healthy females aged between 18 and 26 years, based in Barbados
- Group 0 sample size Number of subjects in the control (unexposed) group
- 174
- Group 1 sample size Number of subjects in the case (exposed) group
- 32
Lab analysis
Statistical Analysis
Signature 1
Source: Table S13
Description: Differentially abundant taxa in oral samples between Barbados and other locations.
Abundance in Group 1: increased abundance in Barbados
NCBI | Quality Control | Links |
---|---|---|
Actinomyces sp. oral clone DR002 | ||
Alistipes_sp._627Alistipes_sp._627 |
Revision editor(s): KateRasheed
Signature 2
Source: Table S13
Description: Differentially abundant taxa in oral samples between Barbados and other locations.
Abundance in Group 1: decreased abundance in Barbados
Revision editor(s): KateRasheed
Experiment 9
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Barbados, South Africa, Thailand
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- Chile
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- Chile refers to the samples from healthy females aged between 18 and 26 years, based in Chile.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 137
- Group 1 sample size Number of subjects in the case (exposed) group
- 69
Lab analysis
Statistical Analysis
Signature 1
Source: Table S14
Description: Differentially abundant taxa in oral samples between Chile and other locations.
Abundance in Group 1: increased abundance in Chile
NCBI | Quality Control | Links |
---|---|---|
unclassified Streptococcus |
Revision editor(s): KateRasheed
Signature 2
Source: Table S14
Description: Differentially abundant taxa in oral samples between Chile and other locations.
Abundance in Group 1: decreased abundance in Chile
Revision editor(s): KateRasheed
Experiment 10
Subjects
- Group 0 name Corresponds to the control (unexposed) group for case-control studies
- Barbados, Chile, Thailand
- Group 1 name Corresponds to the case (exposed) group for case-control studies
- South Africa
- Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
- South Africa refers to the samples from healthy females aged between 18 and 26 years, based in South Africa.
- Group 0 sample size Number of subjects in the control (unexposed) group
- 169
- Group 1 sample size Number of subjects in the case (exposed) group
- 37
Lab analysis
Statistical Analysis
Signature 1
Source: Table S15
Description: Differentially abundant taxa in oral samples between South Africa and other locations.
Abundance in Group 1: increased abundance in South Africa
Revision editor(s): KateRasheed
Signature 2
Source: Table S15
Description: Differentially abundant taxa in oral samples between South Africa and other locations.
Abundance in Group 1: decreased abundance in South Africa
Revision editor(s): KateRasheed